Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
AGING Analysis Report
Jul 27, 2026
27 days ago · 100% complete
NOT DEPENDABLE This report predates a filing — its financial basis has been replaced.
Report generated: Jul 27, 2026 · Filing on record since: Aug 19, 2026 · 23 days after
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for CBRE Group Inc. (CBRE) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-08-23): Designation Low · Gem Score -24 (−100…+100 Quality+Value blend) · Quality 25 · Value -64 · Sentiment -8 (timing only, not weighted) · Composite fair value $175.12 vs $139.46 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

CBRE Group Inc.

CBRE NYSE
Real Estate · Real Estate Services
Dallas, TX 75201, United States cbre.com Updated Jul 26, 10:52am
Price
$139.46
Market Cap
$40.8B
Employees
155,000
Beta
1.21
Avg Volume
1,830,273
CEO
Mr. Robert E. Sulentic

CBRE Group Inc. is a global commercial real estate services and investment company headquartered in Dallas, Texas. The firm provides a comprehensive suite of services that support both real estate investors and occupiers across office, industrial, retail, multifamily, and specialized property types. CBRE Group Inc. organizes its activities around advisory services such as leasing, property sales, capital markets, and valuation; global workplace solutions including facilities management, project management, and outsourced real estate operations; and real estate investments encompassing property development, investment management, and related services. The company plays a central role in the professional real estate ecosystem by connecting capital, occupiers, and developers, and by managing properties and critical infrastructure on behalf of corporations, institutions, and public-sector clients in more than 100 countries. Founded in 1906 and incorporated in its current form in Delaware, CBRE Group Inc. is recognized as one of the world’s largest and most diversified commercial real estate platforms.

Runs with full report Generated: Jul 27, 2026 12:29am
Price Overview
Price at report time
$139.46
as of Jul 27, 12:35am (27d ago)
Change · Jul 27
+3.91 (+2.88%)
Day Range
$136.27 – $140.61
52-Week Range
$121.69 – $174.27
50-Day MA
$134.33
200-Day MA
$148.11
Volume
1,488,100.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 27d).
Share Structure
Outstanding 292,840,522.00
Float 290,819,570.00
Free Float 99.3%
High free float — 99.3% of shares trade freely, ~0.7% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jul 27, 2026 12:44am (27d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jul 27, 2026 12:44am (27d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Jul 27, 2026 12:28am
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
36.22
Stock Price: $139.46
EPS (Diluted): 3.85
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
4.72
Stock Price: $139.46
Total Equity: $8.88B
Shares: 300,519,481
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
26.55
Market Cap: $40.84B
Total Debt: $9.99B
Cash: $1.86B
EBITDA: $1.57B
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$41.6B
Market Cap: $40.84B
Total Debt: $9.99B
Cash: $1.86B
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
18.7%
Gross Profit: $7.57B
Revenue: $40.55B
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
3.2%
Operating Income: $1.29B
Revenue: $40.55B
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
2.9%
Net Income: $1.16B
Revenue: $40.55B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
13.0%
Net Income: $1.16B
Total Equity: $8.88B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
6.1%
Operating Income: $1.29B
Tax Rate: 19.9%
Equity: $8.88B
Total Debt: $9.99B
Cash: $1.86B
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
1.09
Current Assets: $13.49B
Current Liabilities: $12.32B
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
1.13
Short-Term Debt: $2.82B
Long-Term Debt: $7.17B
Total Debt: $9.99B
Total Equity: $8.88B
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$134.93
Revenue: $40.55B
Shares: 300,519,481
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$29.54
Total Equity: $8.88B
Shares: 300,519,481
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$3.97
Operating CF: $1.56B
CapEx: $0.00
Shares: 300,519,481
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
Last Dividend: $0.00
Stock Price: $139.46
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $1.16B
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jul 27, 2026 12:17am
Compares CBRE against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Jul 27, 2026 12:44am (27d ago)
Metric 2021 2022 2023 2024 2025
Revenue $27.7B $30.8B $31.9B $35.8B $40.6B
Cost of Revenue $21.6B $24.2B $25.7B $28.8B $33.0B
Gross Profit $6.2B $6.6B $6.3B $7.0B $7.6B
Operating Expenses $4.6B $5.3B $5.2B $5.7B $6.3B
Operating Income $1.6B $1.3B $1.1B $1.3B $1.3B
Net Income $1.8B $1.4B $986.0M $968.0M $1.2B
EBITDA $2.0B $1.8B $1.7B $1.8B $1.6B
EPS $5.48 $4.36 $3.20 $3.16 $3.88
EPS (Diluted) $5.41 $4.29 $3.15 $3.14 $3.85
Balance Sheet (Annual)
Last updated: Jul 27, 2026 12:37am (27d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $2.4B $1.3B $1.3B $1.1B $1.9B
Total Current Assets $10.1B $8.5B $9.7B $10.0B $13.5B
Total Assets $22.1B $20.5B $22.5B $24.4B $30.9B
Current Liabilities $8.4B $8.2B $8.2B $9.3B $12.3B
Long-Term Debt $2.7B $2.2B $3.9B $4.6B $7.2B
Total Liabilities $12.7B $11.9B $13.5B $15.2B $21.3B
Total Equity $8.5B $7.9B $8.3B $8.4B $8.9B
Retained Earnings $8.4B $8.8B $9.2B $9.6B $9.9B
Cash Flow (Annual)
Last updated: Jul 27, 2026 12:44am (27d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $2.4B $1.6B $480.0M $1.7B $1.6B
Capital Expenditure -$209.9M -$260.1M
Free Cash Flow $2.2B $1.4B
Acquisitions (net)
Net Debt Issued / (Repaid) $492.3M $0
Dividends Paid
Stock Buybacks -$368.6M -$1.9B -$665.0M -$627.0M -$968.0M
Net Change in Cash $500.5M -$1.1B -$34.0M -$150.0M $793.0M
Growth Trends (YoY %)
Last updated: Jul 27, 2026 12:44am (27d ago)
Metric 2022 2023 2024 2025
Revenue Growth +11.1% +3.6% +12.0% +13.4%
Gross Profit Growth +6.9% -4.8% +10.9% +8.8%
Operating Income Growth -15.3% -17.9% +16.6% +1.8%
Net Income Growth -23.4% -29.9% -1.8% +19.5%
EBITDA Growth -13.1% -4.1% +7.0% -13.1%
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable 18 computed · 6 not applicable
Risk : Reward — if the last quarter repeats
Live · as of 2026-08-19 08:41
0.6 : 1 recovery upside vs repeat-quarter downside
Recovery pays +39%; another quarter like the worst recent one costs 66%. Ratio 0.6:1.
CaseGrowthMarginFair valuevs price ($139.46)
Bull — recovery +23% 9.2% $193.68 +39%
Base — stabilizes +15% 8.0% $134.61 -3%
Bear — keeps slipping +8% 6.8% $90.83 -35%
Stress — last quarter repeats +12% 2.8% $46.75 -66%
The next quarters keep the trajectory of the worst recent matched quarter (ending 2025-12-31) — growth stays at 12.5% and margins bend by the same profit-vs-revenue ratio (×0.93). Stress is a trajectory, not a prediction — it answers "what if the ship's current heading simply continues," which history says is the case to respect.
Why this is appearing: this company files quarterly, so its recent trajectory could be measured rather than assumed — the engine matched Jun 2026, Mar 2026 against the same quarters one year earlier and found revenue +17.0% · operating income +34.8% · net income +38.1% year-over-year. That measured heading is what the stress case extends forward. Of those, the stress case extends the worst matched quarter — the one ending Dec 31, 2025 (revenue +12.4%, operating income +4.5% YoY) — not the average. Data measured through Jun 30, 2026 — this card recalculates automatically when the next quarterly filing is ingested. Companies without quarterly filings (many foreign listings) never show this card: with no measured trajectory, there is nothing honest to repeat.
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for CBRE — it's generated by the pipeline (market-narrative step).
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-07-27 00:44:28
Verdict Overvalued cyclical dressed as a compounder — fair value $95-105 on mid-cycle earnings power; avoid until either capital markets volumes re-accelerate or the multiple compresses to sub-25x.

Starting with the raw numbers before touching the model outputs: CBRE printed $40.55B revenue in 2025 vs $27.75B in 2021 — a real 12.7% CAGR, that's not fake. But look at what happened to profitability along the way: net income went from $1.84B (2021) to $1.16B (2025), operating margin collapsed from 5.7% to 3.2%, and gross margin slid from 22.2% to 18.7%. That is not a "capital-light platform in transition" — that's a services roll-up absorbing lower-margin facilities/outsourcing revenue (GWS-style contracts) that dilute mix while the high-margin capital markets and leasing brokerage lines got hammered by rate-driven transaction drought. The Q1 2025 print ($8.88B rev, 1.8% margin) vs Q4 2024 ($10.41B, 4.7%) shows the extreme seasonality/back-end-loading typical of brokerage — this is emphatically a cyclical services business, not a SaaS platform.

The valuation math is where I get uncomfortable. $40.84B market cap on $1.16B net income is 35x trailing, and EV/EBITDA at 26.5x is genuinely rich for a business whose *peak* net income was $1.84B in the ZIRP-fueled 2021 transaction boom. Even if you underwrite a full capital markets recovery back to 2021 earnings power ($1.84B), you're paying 22x peak-cycle earnings for a business with $9.99B of debt against $1.86B cash and $8.88B equity — leverage that matters when brokerage revenue can drop 30% in a quarter. FCF of $1.19B against a $40B+ EV is a ~3% FCF yield. The "161% FCF CAGR" momentum number is a base-effect artifact — 2022-2023 FCF was crushed, so any recovery looks parabolic. Don't be fooled by it.

Where I part with the prior models: the pre-flight framing of "services-platform-hybrid" and the narrative layer's "steady-compounder" archetype both give CBRE too much credit for a transformation that the margin data actively refutes. If workplace solutions were building software-like recurring economics, you'd see gross margin *expansion*, not a 350bp contraction over five years. The synthesis "Priced for Perfection" verdict is directionally right but the reasoning ("50% FCF growth required") leans on that noisy FCF CAGR. The Market Forces "Neutral" call is too generous — this is a rate-sensitive, office-exposure-heavy cyclical trading at a growth multiple heading into a period where the 10Y and office vacancy are both structural headwinds. The insider activity data is useless here (gifts and awards, no open-market buying visible, dated 2026 which is either a data error or forward-dated filings — flag it).

The contrarian case for the bulls: CBRE is genuinely the #1 global CRE services franchise, GWS (Global Workplace Solutions) is a real annuity-like business with 90%+ retention, and if/when capital markets transaction velocity mean-reverts, the operating leverage is violent — 2021 showed $1.84B NI is achievable, and a normalized cycle midpoint might be $1.5B, putting forward P/E closer to 27x. That's still not cheap, but it's defensible for a #1 franchise. However, the bull case requires (a) office to stabilize, (b) rates to normalize enough to reawaken deal flow, and (c) GWS margins to actually expand rather than dilute. Zero of those three are visible in the current data. I agree with the synthesis verdict but for different reasons: it's not that the model is wrong to call "Priced for Perfection," it's that the model underweights the cyclicality risk and overweights the platform-transformation narrative on the way to that conclusion. Fair value on a mid-cycle $1.5B NI at 18-20x (appropriate for a leveraged cyclical services leader) is $27-30B market cap, or ~$95-105/share. The current $139 embeds ~35-45% narrative premium for a transformation the P&L doesn't corroborate.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-07-27 00:44:44
Verdict I agree with Opus that CBRE is overvalued at $139, but I’m less bearish on fair value — I’d place it around $110-120 rather than $95-105, reflecting franchise quality without buying the compounder narrative.

What jumps out to me in the raw data is not simply “cyclical brokerage weakness,” but a business whose revenue mix has changed so much that revenue growth has become a worse indicator of value creation than it used to be. CBRE has taken revenue from $27.75B in 2021 to $40.55B in 2025, yet operating income fell from $1.57B to $1.29B and net income from $1.84B to $1.16B. That is a brutal trade: 46% more sales for 18% less operating profit and 37% less net profit. Gross profit only rose from $6.17B to $7.57B over that span, so most of the top-line gain came at much lower incremental economics. The quarterly pattern reinforces that this is a low-margin volume machine, not an emerging high-margin platform: over the last five reported quarters, revenue ranged from $7.94B to $10.41B while net margin stayed in a narrow 1.5%-4.7% band, with the most recent quarter at just 1.8%. I see a stronger franchise than a commodity broker, but the numbers describe a scaling service network with weak incremental margins, not a business on the cusp of software-like operating leverage.

The balance sheet and cash flow add a second important layer. Net debt is roughly $8.1B against $8.88B of equity, so this is not distressed, but neither is it a pristine balance sheet for a company producing only $1.29B of operating income and $1.19B of free cash flow. At the current $40.84B market cap, investors are paying about 34-35x trailing earnings and roughly a 2.9% FCF yield for a business with 3.2% operating margins and 2.9% net margins. That combination is the core issue for me. You do not need to believe office is permanently broken to find the stock expensive; you only need to believe that a low-margin global services leader should not command a multiple that assumes either a sharp cyclical rebound or a structural margin step-up. The market is effectively capitalizing quality and scale as if they can offset mediocre economics. I do not buy that at $139.

I agree with Opus on the big call: the stock is overvalued, and the “compounder” framing is too generous relative to the current P&L. Opus argues this is “a services roll-up absorbing lower-margin facilities/outsourcing revenue,” and the data backs that. Gross margin fell from 22.2% in 2021 to 18.7% in 2025 while operating margin dropped from 5.7% to 3.2%; that is classic mix dilution, not evidence of latent platform economics. I also agree with Opus that the 161% FCF CAGR in the model outputs is basically unusable as a valuation anchor. With FCF at $1.19B on a $40.84B equity value, the current cash return is plainly thin, and the “parabolic” growth framing overstates what is likely just recovery from a depressed base. I further agree that the insider data should be ignored; gifts and awards dated 2026 tell us nothing actionable about conviction.

Where I part company with Opus is mainly on magnitude and on what the cyclicality implies for valuation. Opus says “fair value $95-105 on mid-cycle earnings power” and frames $1.5B of net income as a reasonable midpoint. I think that is too punitive for the franchise quality and too anchored to troughish sentiment. If CBRE can earn $1.16B in a still-imperfect environment after already rebuilding revenue to $40.55B, then a normalized earnings band of roughly $1.35B-$1.50B seems plausible without requiring a return to 2021’s $1.84B boom conditions. For a clear category leader with diversified service lines and solid cash generation, I would not insist on only 18-20x normalized earnings as Opus does; 22-24x is more defensible even for a cyclical services name of this quality. That still does not justify today’s price: on $1.35B-$1.50B, that framework supports something more like a $30B-$36B equity value, or roughly $103-$123 per share, not $139. So I agree the stock is expensive, but I think Opus’s $95-105 range leans too bearish unless you assume little or no margin recovery at all.

A careful skeptic of both my view and Opus’s would say we are both over-reading margin compression as permanent deterioration. They would point out that annual revenue climbed from $31.95B in 2023 to $35.77B in 2024 and then to $40.55B in 2025, while net income also recovered from $968M in 2024 to $1.16B in 2025, suggesting the earnings engine may already be reaccelerating. That skeptic would also argue that a 1.0x sales multiple and 1.0x EV/revenue are not absurd for the global leader in an essential outsourced function, especially if transaction activity rebounds faster than expected and drops through at higher margins. That is the real risk to the bear case. But even granting that, the current valuation already asks investors to pay up before that margin recovery is visible in the numbers.

Grok Reading
Grok (xAI) reads the identical raw briefing blind — one of the Big-3 independent readings — and commits to its own verdict.
No Grok reading yet for CBRE — it's generated by the pipeline (grok-critique step) alongside the other Big-3 seats, when a report is run on this ticker.
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-07-27 00:53:04
Delvantic - Cairn AI
Quality - wait for a dip 7/10
Solid platform business (quality +25) trading about 8% rich (value -64) into a mild sentiment headwind (-8) - a classic wait-for-price setup, not a buy here.
The cruxWhether transaction volumes and margins recover enough to grow into today's $139 price, or the market re-rates down toward the $129 deserved value as the margin bleed persists.
Forensic checks Derived mechanically from CBRE's filed financials — not from the AI lenses
Liquidity & RunwaySelf-Funding
DilutionShare Count Shrinking
Earnings QualityHigh Earnings Quality
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+25
Solid
edge √Σ 117 · risk √Σ 92 · conf 7/10

CBRE is a mature, global real estate services platform running at $40.55B revenue in 2025, up from $27.75B in 2021 (roughly 10% revenue CAGR). It throws off real cash - $1.56B FCF in 2025, OCF/NI of 1.21x, accruals at -1.1% of assets, Beneish M of -2.4 and Altman Z of 3.1 - all consistent with clean, well-supported earnings. Capital allocation is shareholder-friendly: diluted shares fell from 339.6M to 300.5M (about -3% CAGR), and buybacks run 6.3x SBC while SBC itself is only 0.3% of revenue - a genuinely disciplined comp structure for a services firm. The concern is quality of growth. Gross margin has slid every year from 22.2% (2021) to 18.7% (2025), and operating margin compressed from 5.6% to 3.2% even as revenue grew ~46%. Net income is still below the 2021 peak of $1.84B despite $12.8B more revenue - operating leverage is running the wrong way. The balance sheet is a constraint: net debt of $8.13B, and $2.82B of short-term debt against $1.86B liquid cash creates refinancing exposure, though $1.56B annual FCF comfortably services it. Insider tape is neutral-to-soft: zero open-market buys, ~$1.76M in sales over 12 months, with recent activity dominated by awards and gifts. Nothing alarming, but no conviction signal either. Overall a solid, durably profitable operator with real earnings and shareholder-aligned capital returns, held back from a higher grade by cyclical margin erosion and a levered balance sheet.

Strengths 4
m70
Clean earnings quality
OCF/NI 1.21x, accruals -1.1% of assets, Beneish M -2.4, Altman Z 3.1 - mechanical checks show no manipulation flags and cash backs the reported profits.
m65
Disciplined share count reduction
Diluted shares fell from 339.6M (2021) to 300.5M (2025), a -3% CAGR, with buybacks at 6.3x SBC and SBC only 0.3% of revenue - per-share value is being concentrated.
m55
Durable cash generation at scale
FCF of $1.56B in 2025 on $40.55B revenue; five-year FCF has averaged roughly $1.4B, self-funding capex, buybacks, and debt service.
m40
Revenue growth despite cyclical headwinds
Revenue grew from $27.75B to $40.55B (2021-2025) - roughly 10% CAGR - showing platform relevance across a difficult commercial real estate cycle.
Concerns 3
m70
Multi-year margin compression
Gross margin fell from 22.2% to 18.7% and operating margin from 5.6% to 3.2% over 2021-2025; net income of $1.16B in 2025 is still below $1.84B in 2021 despite $12.8B more revenue.
m55
Levered balance sheet
Net debt of $8.13B with only $1.86B liquid cash; short-term debt of $2.82B exceeds cash, creating refinancing exposure in a higher-rate environment.
m25
Soft insider signal
Zero open-market buys and ~$1.76M in sales over 12 months; not a red flag, but no conviction signal from those closest to the business.
This is a solid, well-run mature business - not a fortress but not fragile either. The earnings are real, the share count is genuinely shrinking, and management isn't looting the company through SBC. What bothers me is the quiet margin bleed: they've added $12.8B of revenue and gone backwards on net income, which suggests either mix deterioration or that scale isn't translating to leverage in this business the way you'd want. The debt load is manageable given FCF but it's a constraint, not a cushion. I'd call it a good business, not a great one - a capable operator in a cyclical industry rather than a compounder with a moat.
Verify before trusting this (5)
  • Segment mix shift driving the 350bp gross margin decline - is it a structural move toward lower-margin outsourcing/facilities revenue or cyclical weakness in transactions/leasing?
  • Debt maturity schedule and rate structure behind the $2.82B short-term debt to gauge refinancing risk.
  • Acquisition contribution to the 2021-2025 revenue growth (organic vs. M&A) and goodwill/intangibles buildup.
  • Composition of $1.56B FCF - working capital swings vs. underlying earnings power - given the volatile 2023 FCF dip to $480M.
  • Customer/geographic concentration in Global Workplace Solutions and any exposure to office-sector distress.
Valuation / Mispricing
-64
Rich
edge √Σ 32 · risk √Σ 96 · conf 6/10
Price $139.46 vs deserved ~$129 - about 8% overpaid, no margin of safety. attractive below $115.00

The e2e composite pins fair value at $128.93 (signal-adjusted identical), against a market price of $139.46 - roughly an 8% premium to deserved value. That's not egregious, but it's the wrong side of zero for a cyclical services business whose net income has gone backwards even as revenue added $12.8B. The 'Priced for Perfection' tag from the e2e work lines up: buyers here are underwriting a transaction-volume recovery and margin recapture that hasn't shown up in the P&L yet.

Cheap signals 2
m25
High earnings quality supports the number
Earnings-quality score 3 means the $129 FV doesn't need a haircut - the reported cash generation is real, which limits downside from an accounting reset.
m20
Shrinking share count
Genuine buybacks (not SBC offset) quietly lift per-share deserved value over time, cushioning some of the premium.
Rich / priced-in 3
m55
Trades above composite fair value
Price $139.46 vs composite/signal-adjusted FV of $128.93 - roughly 8% premium. Modest but real overpayment given cyclical exposure.
m60
Margin bleed not reflected in the multiple
Revenue up $12.8B yet net income lower - the market is paying a full multiple on earnings that aren't scaling. Deserved multiple should compress until leverage returns.
m50
Priced for a transaction recovery
Advisory and capital-markets fees need volume normalization to justify today's price; if office/transaction activity stays subdued, the FV drifts lower, not higher.
I'm not paying $139 for a $129 business, especially one where scale isn't translating to earnings leverage. This is a fine company at a full-to-slightly-rich price - the classic 'wait' setup. I want a real margin of safety on a cyclical services name; 15-20% below deserved value, call it $115 or lower, is where this gets interesting. Above $130 it's just fairly-to-richly priced and I'd rather own it lower or not at all.
Verify before trusting this (4)
  • Segment margin trajectory in Advisory vs GWS - is the bleed mix or structural?
  • Capital-markets/transaction volume guidance for next 2-4 quarters
  • Any one-time items or acquisition-related costs inflating the revenue-vs-income divergence
  • Leverage and interest expense trajectory into 2025
General Sentiment
-8
Balanced
tail √Σ 57 · head √Σ 65 · conf 6/10

The tape is neutral-to-slightly-risk-off (VIX 18.6, S&P -2.6% off highs, 10y at 4.71%, market PE 26.6) and CBRE's 1.21 beta means it takes a bit more than its share of that pressure. As a Real Estate Services name it also sits directly under the 'rates higher for longer' and 'office structurally broken' overhangs that periodically flare up in the sector narrative. That is a real, if moderate, headwind. Offsetting it, CBRE carries a steady-compounder story with moderate durability - the market treats it as the essential platform layer of global CRE rather than a pure office cyclical, which insulates sentiment somewhat versus REIT peers. The most recent news flow is constructive but low-voltage: a pre-Q2 preview flagging outsourcing and leasing strength, and a bullish European hotel capital-flows piece that reinforces the 'capital is still being deployed' angle. Nothing viral, no analyst tone shock, no cult energy. Net: small headwind from macro, small tailwind from narrative and news, no decisive push either direction into the print.

Tailwinds 2
m45
Compounder narrative is holding
The market still frames CBRE as the essential CRE infrastructure platform (moderate durability, moderate intensity), which cushions it versus pure office-exposed REITs when sector sentiment wobbles.
m35
Constructive pre-print news flow
The Q2 preview highlighting outsourcing and leasing strength, plus the European hotel capital-flows story, keep the 'capital still deploying, fees still compounding' angle intact just ahead of earnings.
Headwinds 3
m45
Beta 1.21 into a soft, high-VIX tape
With VIX in the top quintile and the S&P off its highs, a 1.21-beta cyclical services name absorbs more of the risk-off marking than the average stock, even absent company news.
m40
Rates and CRE overhang linger
10y at 4.71% and market PE 26.6 keep the 'higher-for-longer + broken office' bear frame alive for anyone in Real Estate Services, capping multiple expansion regardless of execution.
m25
Low cult, moderate intensity
There is no fanbase or story momentum to defend the stock on a bad tape day; sentiment is workmanlike, so drawdowns tend to be met with silence rather than dip-buying narrative.
Net, I read this as a mild headwind masquerading as balanced. The macro tape is slightly risk-off and CBRE's beta plus sector exposure mean it eats a bit more of that than average, and there is no cult or high-intensity story to defend it on down days. But the compounder narrative is genuinely holding, recent news is quietly supportive, and analyst tone has not cracked. Absent a fresh rates or office shock, sentiment pressure here is a light drag, not a wave - the kind of setup where the stock drifts with the tape rather than getting singled out.
Verify before trusting this (4)
  • Q2 print reaction and whether analyst tone shifts on outsourcing/leasing guidance
  • Any renewed spike in the 10y or VIX that would reawaken the CRE-rates bear narrative
  • Sector rotation signals - if REITs and CRE services catch a bid on rate-cut repricing, sentiment flips to tailwind quickly
  • Office vacancy or major leasing headlines that could reactivate the structural-bear story
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
not run

This lens hasn't been run for this ticker yet.

The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
About flat -0.3% v0.6.0 View full prediction →

When we made this prediction on Jul 27, 2026, CBRE was $139.46. We expect it to be $139.00 by Jan 2027, and we consider it great value under $115.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Jul 27, 2026.

Price when predicted$139.46
Our estimate for Jan 2027$139.00-0.3%
Great value below$115.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for CBRE. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.562 · 9b2927c4 · 2026-08-22 16:52:06